Pricing

Log inSign up

NRx Pharmaceuticals

0 followers

‌

NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.

Industries

Biotechnology

Headquarters

Wilmington, United States

Employees

11-50

Links

Org chart

Jonathan C. Javitt
Founder & Chief Scientist
RP
Rick Panicucci
Chief Technology Officer
Dennis K. McBride
Chief Strategy Officer & Senior Scientist
MD
Matthew Duffy
Chief Business Officer
PL
Philip T. Lavin
Chief Methodologist
MB
Martin Brecher
Medical Director
MG
M. Daniel Gordin
Regulatory Affairs Officer

Board & advisors

CH
Chaim Hurvitz
Director
SG
Sherry A. Glied
Director
Patrick Flynn
Board Member
AG
Aaron Gorovitz
Director
DJ
Daniel C. Javitt
Co-Founder & Chair, Scientific Advisory Board
WP
Wayne Pines
Regulatory & Patient Advocacy Adviser
MM
Melvin L. Morganroth
Clinical Advisor, COVID-19
HP
Harry B. Peled
Clinical Advisor COVID-19
AN
Andrew Nierenberg
Advisor
ML
Marion Leboyer
Advisor

Teams

DJ
MD
PL
+5

Business Development and Strategy

9 people · 0 jobs

DJ
PL

Leadership Team

4 people · 0 jobs

HP
MG
MB
MM
+2

Medical and Regulatory Affairs

6 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

14 followers

PerkinElmer

11 followers

Explore companies